Subscribe To
Vyant bio ends 2021 with $20.6m in cash as it sharpens focus on novel drug discovery
Vyant Bio (NASDAQ:VYNT) Inc ended its 2021 financial year with a beefed-up cash balance of $20.6 million to help the biotechnology company pursue its ...
March 30, 2022, 12:06 pm
Nuformix says patent application for reformulated astrazeneca blockbuster has progressed to publication phase
Nuformix PLC (LSE:NFX) said its patent application for key asset NXP004 had progressed to the publication phase. Following this, it was able to reveal...
March 28, 2022, 2:56 am
Kghg takes novel approach in tackling decarbonization
Climate change remains an ever-present looming elephant in the room, and the Russia-Ukraine war highlights concerns around the ongoing energy crisis a...
March 25, 2022, 12:53 pm
Celsion corporation to hold year-end 2021 financial results and business update conference call on thursday, march 31, 2022
LAWRENCEVILLE, N.J., March 24, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-base...
March 24, 2022, 9:00 am
Respirerx pharmaceuticals files provisional patent application for lipid-based formulation technology to develop cannabinoids
RespireRx Pharmaceuticals (OTCQB:RSPI) Inc announced that it has filed a provisional patent application for a ...
March 23, 2022, 9:51 am
Tracon pharmaceuticals to present at the maxim group 2022 virtual growth conference
SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the develop...
March 23, 2022, 8:05 am
Pds biotechnology reschedules 2021 fourth quarter and full year financial results and conference call
FLORHAM PARK, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing...
March 22, 2022, 7:30 pm
Volkswagen (vwagy) to break ground with id.buzz, ota 3.0 software
Volkswagen's (VWAGY) North American investment of $7.1 billion including ID.Buzz will likely aid its presence in the EV space. Its OTA 3.0 software up...
March 22, 2022, 2:17 pm
Pulse biosciences schedules fourth quarter and full year 2021 financial results conference call for march 31, 2022
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine ...
March 21, 2022, 4:05 pm
Wellbeing digital sciences says its kgk science subsidiary engaged by lophos pharmaceuticals for novel peyote study
Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc announced that its wholly-owned subsidiary, KGK Science Inc has been engaged by Lophos Phar...
March 21, 2022, 8:26 am
Pardes biosciences to present at the international conference on antiviral research 2022
CARLSBAD, Calif. , March 21, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing P...
March 21, 2022, 7:00 am
Eliem therapeutics to present at stifel's 2022 cns days
SEATTLE and CAMBRIDGE, United Kingdom, March 21, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology comp...
March 21, 2022, 7:00 am
Illumina (ilmn) debuts tso comprehensive test in europe
Illumina's (ILMN) novel CE-marked IVD kit for comprehensive genomic profiling will enable clinicians to...
March 18, 2022, 12:02 pm
I-mab to report full year 2021 financial results and provide corporate update on march 29, 2022
SHANGHAI and GAITHERSBURG, MD, March 18, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committ...
March 18, 2022, 8:00 am
Miromatrix to report fourth quarter and full year 2021 financial results
EDEN PRAIRIE, Minn., March 17, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a ...
March 17, 2022, 4:01 pm
Neximmune, zephyr join forces for oncology target discovery, validation
NexImmune Inc (NASDAQ: NEXI) and Zephyr AI have announced a strategic partnership focusing on discovering and validating ...
March 17, 2022, 10:00 am
Applied therapeutics to present at the 2022 annual clinical genetics meeting of the american college of molecular genetics and genomics
NEW YORK, March 16, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeli...
March 16, 2022, 7:30 am
Iovance biotherapeutics to present at upcoming conferences
SAN CARLOS, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing
March 16, 2022, 7:01 am
What's going on with incannex healthcare's stock today?
Incannex Healthcare Ltd (NASDAQ: IXHL) is soaring Tuesday on abnormally-high volume. The stock has been extremely volatile since the company released ...
March 15, 2022, 11:48 am
Enveric biosciences touts the publication of four patent applications for psychedelic-inspired drug candidates
Enveric Biosciences (NASDAQ:ENVB) Inc announced that the company's first four Patent Cooperation Treaty (PCT) applications for the tryptamine family o...
March 15, 2022, 8:57 am